Neoplasia/BPH

	Reprogramming prostate cancer through the microbiome. Front Med (Lausanne) Bautista J, Cardona-Maya WD, Gancino-Guevara K, López-Cortés A. PMID: 41384118 [PubMed]
	MRI performance to identify clinically significant prostate cancer following focal cryo-ablation. BJUI Compass Lepor H, Parry S, Tafa M, Rapoport E, Wysock JS. PMID: 41383882 [PubMed]
	Onabotulinumtoxin intra-detrusor injection for lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Caspian J Intern Med Soltanzadi A, Mirmosayyeb O, Momeni Moghaddam A, Vaheb S, Ghajarzadeh M. PMID: 41383791 [PubMed]
	BI04 Bullous pemphigoid induced by cemiplimab to treat metastatic squamous cell carcinoma in a renal transplant patient. Br J Dermatol Freneat M, Li L, Shakir R, Abuleis H, Lloyd-Lavery A. PMID: 41382549 [PubMed - indexed for MEDLINE]
	BI16 The COAST (Contemporary Outcomes After cutaneous SCC in Transplant recipients) study: final results and implications for management following the first cutaneous squamous cell carcinoma in kidney transplant recipients. Br J Dermatol Peleva E, Crisp T, Cernova J, Nawab K, Gauci MA, Gamble J, Wijayawickrama B, Ahmed R, Moriarty J, Matin R, Abbott R, Darvay A, Shah F, Archer C, Muirhead N, Owen A, Bhandary N, Wakefield H, Babu A, Wallin E, Sharif A, Griffin S, Thuraisingham R, Bailey P, Karn EE, Solomon B, Ruiz ES, Harwood C, Bottomley M. PMID: 41382460 [PubMed - indexed for MEDLINE]
	Theranostic potential of MXene-based platforms for dual MiRNA targeting in metastatic bladder cancer. Cancer Cell Int Jazi NN, Alavimanesh S, Vafadar A, Choubani M, Alashti SK, Moradi F, Savardashtaki A. PMID: 41382168 [PubMed - as supplied by publisher]
	Sarcopenia measured by artificial intelligence as a predictor of overall survival in localized bladder cancer, a multicenter study. BMC Cancer Blondeau A, Pitout A, Manuguerra A, Eschwege P, Mazeaud C, Lambert A. PMID: 41382062 [PubMed - as supplied by publisher]
	A novel migrasome-associated lncRNA model for clear cell renal cell carcinoma prognosis and immune response prediction. Sci Rep Zhang L, Dong L, Tian T, Liu J, Zhang H, Zhang W. PMID: 41381760 [PubMed - as supplied by publisher]
	Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer-Oncological Outcome from Long-term Follow-up. Eur Urol Focus Himmelsbach R, Spohn SKB, Grosu AL, Meyer PT, Franz J, Astheimer S, Grabbert M, Sigle A, Schultze-Seemann W, Gratzke C, Jilg CA. PMID: 41381330 [PubMed - as supplied by publisher]
	Re: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. The PRIME Diagnostic Clinical Trial. Eur Urol Pattou M, Peyrottes A, Long-Depaquit T, Tokarski E, Baboudjian M. PMID: 41381295 [PubMed - as supplied by publisher]
	Disparities and temporal trends in referral for bladder cancer diagnosis: A worsening epidemic. Urol Oncol Myers AA, Duan Z, Igel DA, Steinmetz AR, Grajales V, Bree KK, Zhao H, Giordano SH, Kamat AM. PMID: 41381259 [PubMed - as supplied by publisher]
	Immune-related adverse events associated with immune checkpoint inhibitor therapy in bladder cancer patients: A systematic review and meta-analysis. Urol Oncol Gokhale P, Akosah A, Villa Zapata L. PMID: 41381258 [PubMed - as supplied by publisher]
	CD70-Targeted [(18)F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study. J Nucl Med Ma C, Cao M, Li L, Wu Q, Zhang Y, Xu D, An S, Wu Y, Wang C, Guan Y, Kong W, Zhang J, Xie F, Zhai W, Huang G, Liu J, Zhao X, Wei W. PMID: 41381240 [PubMed - as supplied by publisher]
	Letter to the editor regarding the article "Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study". Urol Oncol Besiroglu H, Kadihasanoglu M. PMID: 41381167 [PubMed - in process]
	Evaluation of event-free survival as a surrogate for overall survival in genitourinary rhabdomyosarcoma. Urol Oncol Cheng Z, Campbell T, Hunt TC, Li A, Ceraolo C, Doersch K, Bandari J. PMID: 41381166 [PubMed - indexed for MEDLINE]
	Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30). Radiother Oncol Sargos P, Pignot G, Bellera C, Pommier P, Martin E, Clavere P, Hennequin C, Hoepffner JL, Marcq G, Roumiguié M, Crouzet S, Cormier L, Schartner V, Huchet N, Pasquier D, Khalifa J. PMID: 41380977 [PubMed - as supplied by publisher]
	Interplay of IL-6, GDF-15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on Survival. J Cachexia Sarcopenia Muscle Engelmann SU, Kasparbauer F, Pickl C, Del Giudice F, Haas M, Rinderknecht E, Siska PJ, Pichler R, Niessen C, Burger M, Gu, Mayr R. PMID: 41380167 [PubMed - indexed for MEDLINE]
	Multiple primary cancers with prostate malignant tumor as the initial diagnosis: a case report. Discov Oncol Yang K, Zhou J. PMID: 41379263 [PubMed - as supplied by publisher]
	Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis. S Afr Med J Brits E, Gerber E, Iroka I, Mgidlana L, Willoughby J, Dhlamini S, Nxumalo P, Sefadi S, Mthembu A, Sempa JB. PMID: 41378549 [PubMed - indexed for MEDLINE]
	Revolutionizing the management of enlarged prostate: unveiling the success of robot-assisted simple prostatectomy using Versius robotic system. J Pak Med Assoc Qureshi HH, Mahar NA, Mohsin R, Leghari RA, Fayyaz M, Qamar U. PMID: 41378392 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 183888

Page 1 of 9195



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy